Executive Director Global Medical Affairs, Hematology
ExternalPrepare for this interview
EliteAI-generated questions, company research, and talking points tailored to this role
Benefits
Additional Information
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer. The Executive Director, Global Medical Affairs (ex-China) for Hematology will report directly to the Vice President, Hematology Lead for GMA. She/he will be responsible for developing and implementing all aspects of the global medical strategy for one or more assigned BeOne Hematology assets. The primary focus will be to lead and ensure execution of all programs and functions associated with the assigned Hematology program(s) in Chronic Lymphocytic Leukemia (CLL), mantle cell and marginal zone lymphomas (MCL, MZL), and Waldenstrom Macroglobulinemia (WM). In addition to leading the strategy and executional elements of phase IV (post-marketing) and investigator-initiated studies programs, the role includes broad collaboration with colleagues from clinical development and commercial, in particular for launch preparation and execution, and to ensure that cross-functional plans and activities benefit from the insight of an experienced clinician. The incumbent will apply scientific rigor and data-driven approaches to evidence generation and insight synthesis to inform and support business decisions for assigned hematology product(s), as well as healthcare decision-making by patients, physicians, and payers. The role requires strong strategic planning and execution, collaboration, and clear communication skills to work effectively across internal and external stakeholders. Essential Functions of the Job: Overall Global Medical Strategy & Execution Contributes and/or co-leads the cross-functional Global Medical Team for Hematology; develops and updates, as needed, the overall Global Medical Plan for one or more late-stage hematology molecules and other relevant hematology assets, including Medical launch strategic and tactical plans. Integrated evidence generation plans, incl. but not limited to medical affairs clinical studies, Investigator Initiated Studies (IIS) and RWD. Advisory board plans. External engagement plans. Scientific communication: publication plans, congress presentations, MSL materials. Medical Education plans. Represents the GMA function on the Global Product Team(s) Contributes to the identification of potential medical interests for line extensions according to scientific rationale and good understanding of the actual and anticipated future directions of medical practice. Assesses the needs and coordinates compassionate use together with heads of regions for the assigned product(s). Drives the execution of medical tactics and deliverables, in collaboration with other medical and non-medical functions as needed and appropriate. Reviews and assesses all IIS proposals as per BeOne IIS review process and ensures it is consistent with the asset strategy and identified data gaps. Prepares and leads or co-leads with the VP Hematology for GMA, the scientific advisory board meetings for the assigned product(s). External Collaborations Develops and maintains interactions and collaborations with therapeutic experts and scientific entities, including those aimed to set up and conduct evidence generation activities for CLL, MCL, WM, and MZL. In close collaboration with the GMA Patient engagement & Professional Societies Lead and the Corporate patient advocacy group, actively supports BeOne engagement of patients and patient groups and incorporates insights from these stakeholders into all relevant plans and tactics. Represents BeOne Medicines in peer-to-peer interactions with external collaboration partners, including in patient-company interactions. Collaboration with regional and country medical teams Ensures the cascading and understanding of the global medical plans by medical teams in all regions and countries and drives the alignment of local/regional medical plans to the approved global strategy. Where exceptions are needed, supports minimization of local deviations and documentation of the cross functional reviews & approvals of said deviation by the global team. Regularly liaises with regional/local leads for hematology to gather and incorporate feedback and insights from the markets into the global strategy and plans. As appropriate, supports local/regional external engagement projects by attending meetings, presenting data and/or discussing global collaborations with external hematology stakeholders along with the local/regional teams. Cross-functional collaboration In alignment with the VP Hematology Lead, GMA, works closely with and acts as an internal medical, clinical, and practice subject matter expert for internal teams seeking medical input into drug- or non-drug-related projects and strategic planning, including market access, brand and lifecycle strategies and plans (e.g. Life C